Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 251.99$. Average daily volumn in 3 months 924.33k. Market cap 66.71B



Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 233.92$. Total volume : 1.44M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price
233.92$
Change
-3.27
Volume
1.44M

Previous Close237.19
Open235.77
Day Range230.62-236.86
Bid229.76 x 800
Ask236.26 x 1k
Volume1.44M
Average Volume924.33k
Market Cap66.71B
Beta0.59
52 Week Range229.40-277.29
Trailing P/E35.55
Foward P/E19.16
Dividend (Yield %)1.49%
Ex-Dividend Date2022-09-08



Financial Details


According to Becton, Dickinson and Company's financial reports the company's revenue in 2021 were 20.25B an increase( +17.65%) over the years 2020 revenue that were of 17.12B. In 2021 the company's total earnings were 2.09B while total earnings in 2020 were 874M( +128.83%).


Loading ...



Organization

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and ... extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Market Cap:
66.71B
Revenue:
20.25B
Total Assets:
53.87B
Total Cash:
2.28B


News about "Becton, Dickinson and Company"

becton-dickinson-and-company-nysebdx-shares-sold-by-allworth-financial-lp-image

Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Allworth Financial LP

Source from : Defense World - 2 days ago

Allworth Financial LP cut its holdings in Becton, Dickinson and Company (NYSE:BDX – Get Rating) by 1.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and ...See details»


Becton Dickinson and Co

Source from : Reuters - 2 days ago

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and ...See details»


cambridge-investment-research-advisors-inc-grows-stock-holdings-in-becton-dickinson-and-company-nysebdx-image

Cambridge Investment Research Advisors Inc. Grows Stock Holdings in Becton, Dickinson and Company (NYSE:BDX)

Source from : Defense World - 15 hours ago

Cambridge Investment Research Advisors Inc. increased its stake in shares of Becton, Dickinson and Company (NYSE:BDX – Get Rating) by 4.1% during the second quarter, according to the company in its ...See details»


Just Four Days Till Becton, Dickinson and Company (NYSE:BDX) Will Be Trading Ex-Dividend

Source from : Nasdaq - 22 days ago

It looks like Becton, Dickinson and Company (NYSE:BDX) is about to go ex-dividend in the next four days. The ex-dividend date is one business day before a company's record date, which is the date ...See details»


R.I. jury orders Becton Dickinson to pay $4.8 mln in hernia mesh trial

Source from : Reuters - 27 days ago

Verdict is largest so far over BD's hernia repair mesh Company faces more than 30,000 similar cases (Reuters) - Becton, Dickinson and Co's C.R. Bard Inc subsidiary must pay $4.8 million in a ...See details»


BDX Becton, Dickinson and Company

Source from : Seeking Alpha - 4 days ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»


Four Days Left To Buy Becton, Dickinson and Company (NYSE:BDX) Before The Ex-Dividend Date

Source from : Yahoo Finance - 22 days ago

Readers hoping to buy Becton, Dickinson and Company (NYSE:BDX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one ...See details»


Becton Dickinson taps Johnston County for new manufacturing plant

Source from : The Business Journals - 19 days ago

A global medical technology company is expanding its footprint in Johnston County with plans for a new manufacturing operation. Becton, Dickinson and Company (NYSE: BDX) will invest between $25 ...See details»


Diabetes Devices Market Analysis and Advancements Outlook 2022 to 2029 – Becton, Dickinson and Company, Novo Nordisk

Source from : MarketWatch - 3 days ago

The Global Diabetes Devices Market Size was estimated at USD 21173.27 million in 2021 and is projected to reach USD 32607.84 million by 2028, exhibiting a CAGR of 6.36% during the forecast period. Top ...See details»


Becton Dickinson's (NYSE:BDX) earnings growth rate lags the 5.5% CAGR delivered to shareholders

Source from : Yahoo Movies UK - 1 days ago

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to ...See details»


BD Promotes Two Senior Executives to Segment Leadership Roles

Source from : Stockhouse - 1 month ago

FRANKLIN LAKES, N.J., Aug. 25, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of two senior leaders ...See details»


With 90% institutional ownership, Becton, Dickinson and Company (NYSE:BDX) is a favorite amongst the big guns

Source from : Yahoo Finance - 24 days ago

To get a sense of who is truly in control of Becton, Dickinson and Company (NYSE:BDX), it is important to understand the ownership structure of the business. With 90% stake, institutions possess the ...See details»


Becton, Dickinson And Q4 2010 Earnings Call Transcript

Source from : TheStreet.com - 13 days ago

Then I'll spend some time highlighting the company's strategy and key focus areas for 2011 and beyond. Next, David will provide a drill down financial view of our company overall and segment ...See details»


this-healthcare-company-is-likely-to-offer-better-returns-over-eli-lilly-stock-image

This Healthcare Company Is Likely To Offer Better Returns Over Eli Lilly Stock

Source from : Forbes - 10 days ago

There is more to the comparison, and in the sections below, we discuss why we believe BDX stock will offer better returns than LLY stock in the next three years.See details»